Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06355973Not ApplicableNot Yet Recruiting

A Pilot Study for Efficacy of Cognitive and Physical Training in Patients With Mild Cognitive Impairment

Role: lead

NCT06330155Not Yet Recruiting

A Genetic Study for Alzheimer Dementia: Case-control Study

Role: lead

NCT06322797Not ApplicableRecruiting

The Safety&Efficacy of Repetitive Transcranial Magnetic Stimulation for Post-Stroke Upper Extremity Function Improvement

Role: lead

NCT01991145Not ApplicableCompleted

Allogeneic UCB Therapy With EPO in Children With CP

Role: lead

All 4 trials loaded